Hers vs MEDGm: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher & Publisher

Reviewed & updated September 1, 2026 · Cites primary sources (FDA, NEJM, CMS) · Not medical advice

53 providers verified independently·Independent research·How we rank →

Short answer: Hers scores higher on our rubric, 5.3/10 against 2.7/10. Full reasoning, pricing and the cases where the other one wins are below.

Visit Hers - our pick of these two →or find your match

Hers beats MEDGm overall, scoring 5.3/10 vs 2.7/10. Published pricing is not a like-for-like monthly comparison: Hers is $188 first month, then $298/mo; MEDGm is from $179/mo. Choose Hers for women who want a female-focused platform and can budget at least $188 initially and $298/mo ongoing for a $149 medication path. Choose MEDGm for shoppers who want a compounded glp-1 with the price visible before intake and are comfortable that no clinician or pharmacy is named.

A side-by-side look at Hers and MEDGm to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

Higher Rated

Hers

#45 of 53

5.3/10

The women's health arm of Hims & Hers Health (NYSE: HIMS). Hers lists Wegovy pill, Foundayo, and Ozempic pill medication from $149, a Wegovy pen from $199, Zepbound from $299, and compounded options. A required Weight Loss Membership adds $39 in month one and $149/mo thereafter, so the all-in floor for a $149 medication path is $188 initially and $298/mo ongoing; exact product and dose prices vary.

Visit Hers

MEDGm

#53 of 53

2.7/10

MEDGm is a telehealth company selling compounded GLP-1 injections from $179/mo and dissolvable tablets from $249/mo, with brand-name Zepbound, Wegovy and Ozempic offered as a membership plus an unpublished medication cost. The compounded prices are readable before intake and the not-FDA-approved disclosure is prominent, which is more than several better-known programs manage. The gap is verification: no clinician, no pharmacy and no accreditation is named anywhere on the site or in its terms.

Visit MEDGm

Feature	Hers	MEDGm
Why each one	A major women-focused telehealth platform with a direct Novo Nordisk partnership (Wegovy pill from $149 and pen from $199 before required membership) and a Lilly partnership (Zepbound medication from $299) alongside compounded options.	Publishes its compounded prices before intake and does not claim an accreditation it cannot support. Both are low bars that a surprising number of programs fail.
Our Score	5.3/10	2.7/10
Headline Price	$188 first month, then $298/mo	from $179/mo
Medication Type	Both	Both
Insurance Accepted	No	No
Best For	Women who want a female-focused platform and can budget at least $188 initially and $298/mo ongoing for a $149 medication path	Shoppers who want a compounded GLP-1 with the price visible before intake and are comfortable that no clinician or pharmacy is named.
Watch out for	Pending federal enforcement action against the parent company. On July 29, 2026 the FTC, joined by Utah and California acting through Los Angeles County Counsel, filed a complaint against Hims & Hers Health, Inc. in the U.S. District Court for the Northern District of California, alleging violations of the FTC Act and the Restore Online Shoppers' Confidence Act over subscription billing, cancellation friction, and sharing consumer health information with advertising platforms. Case status is Pending. These are allegations, not findings.	No medical director, prescribing clinician or medical group is named anywhere
Ranking	#45	#53
Get started	Visit Hers	Visit MEDGm

Pros & Cons Compared

Hers

Pros

+FDA-approved brand paths include Wegovy pill, Foundayo, and Ozempic pill medication from $149 and a Wegovy pen from $199; with the required membership, a $149 medication path totals $188 initially and $298/mo ongoing
+Zepbound access via the Lilly/Hims-Hers partnership announced 2026
+Publicly traded company (NYSE: HIMS) with strong financial backing and regulatory compliance
+Broader women's health platform, integrates weight loss with hormonal, skin, and wellness services

Cons

−Pending federal enforcement action against the parent company. On July 29, 2026 the FTC, joined by Utah and California acting through Los Angeles County Counsel, filed a complaint against Hims & Hers Health, Inc. in the U.S. District Court for the Northern District of California, alleging violations of the FTC Act and the Restore Online Shoppers' Confidence Act over subscription billing, cancellation friction, and sharing consumer health information with advertising platforms. Case status is Pending. These are allegations, not findings.
−Every medication figure excludes the required Weight Loss Membership ($39 first month, then $149/mo); exact product and dose prices can increase the total above the $188/$298 floor
−Support runs at big-platform scale, fine for routine refills, less personal if you want high-touch care
−Compounded pricing starts at $199/mo with stepped pricing at higher doses, budget for the dose you'll end up on, not the entry dose
−Zepbound medication starts at $299 before the required membership; that path totals $338 in month one and at least $448/mo ongoing, with exact dose pricing potentially higher

MEDGm

Pros

+Compounded prices visible on the landing page without starting an intake
+Prominent, correctly-worded disclosure that compounded GLP-1s are not FDA-approved
+Cancel any time, with a published refund policy rather than a buried one
+Claims no accreditation it cannot support, which is rarer than it should be
+HSA/FSA accepted; free shipping stated

Cons

−No medical director, prescribing clinician or medical group is named anywhere
−No compounding pharmacy is named; the terms promise a partner list that the terms do not contain
−Brand-name Zepbound, Wegovy and Ozempic are priced as a membership plus an unpublished medication cost, so no brand total can be compared
−No lab panel is offered or required at any tier
−The homepage claims 120,000+ patients on a domain registered 2026-04-08; we could not reconcile the two
−A prepaid contracted term is non-refundable, and dispensed medication is never refundable
−No third-party rating exists that we could locate and verify

Our Verdict

Hers edges out MEDGm with a score of 5.3/10 vs 2.7/10. Published pricing is not a like-for-like monthly comparison: Hers is $188 first month, then $298/mo; MEDGm is from $179/mo.

Cheapest complete recurring price in our index

Eden Health GLP-1

$99/mo month-to-month, from $34 on a plan · 6.9/10 · Both

Both Hers and MEDGm start above the cheapest complete recurring program we track. Across all 53 providers in our index, the lowest price with affirmative medication, consultation, and shipping inclusion is Eden Health GLP-1 at $99/mo, price checked August 28, 2026. It scores 6.9/10 and is not the highest-scored provider in our full rankings, so this is a cost floor rather than a recommendation. Worth knowing before you decide.